Latest lidocaine Stories
HUNTINGTON BEACH, Calif., April 29, 2013 /PRNewswire/ -- Absorption Pharmaceuticals announced today that the U.S. Patent and Trademark Office has indicated that it will grant a patent related to the use of its topical medication, Promescent, for premature ejaculation (PE). The patent protects novel lidocaine-only eutectic formulation which enables maximum absorption of the anesthetic through the skin's outer layer and provides men with improved ejaculatory control while maintaining...
MISSISSAUGA, ON, April 23, 2013 /PRNewswire/ - Nuvo Research Inc. (TSX: NRI), a specialty pharmaceutical company dedicated to building a portfolio of products for the topical treatment of pain and Galderma Pharma, S.A. (Galderma), today announced the European launch of Pliaglis (lidocaine and tetracaine) Cream 7%/7%. Nuvo has licensed worldwide marketing rights for Pliaglis to Galderma, a global pharmaceutical company specialized in dermatology. Marketing licenses have been...
Data Evaluating Synera(®) for the Treatment of Shoulder Impingement Syndrome MISSISSAUGA, ON, April 19, 2013 /PRNewswire/ - Nuvo Research Inc. (TSX: NRI), a specialty pharmaceutical company dedicated to building a portfolio of products for the topical treatment of pain today announced that researchers presented scientific data related to Synera(®) (70 mg lidocaine/ 70 mg tetracaine) topical patch at the 22(nd) Annual Meeting of the American Medical Society for Sports Medicine...
MISSISSAUGA, ON, March 11, 2013 /PRNewswire/ - Nuvo Research Inc. (TSX: NRI), a specialty pharmaceutical company dedicated to building a portfolio of products for the topical treatment of pain and Galderma Laboratories, L.P., the U.S. affiliate of Galderma Pharma, S.A. (Galderma), today announced the U.S. launch of Pliaglis (lidocaine and tetracaine) Cream 7%/7%. Nuvo has licensed worldwide marketing rights for Pliaglis to Galderma, a global pharmaceutical company specialized in...
MISSISSAUGA, ON, Oct. 22, 2012 /PRNewswire/ - Nuvo Research Inc. (TSX: NRI), a specialty pharmaceutical company dedicated to building a portfolio of products for the topical treatment of pain and Galderma Laboratories, L.P., the U.S. affiliate of Galderma Pharma, S.A. (Galderma), today announced that the U.S. Food and Drug Administration (FDA) has approved a supplemental New Drug Application (sNDA) for Pliaglis® (lidocaine/tetracaine) 7%/7% Cream. Nuvo has licensed worldwide...
AACHEN, Germany, September 5, 2012 /PRNewswire/ -- Targeted Treatment for Patients Suffering from Postherpetic Neuralgia: It's a Control Thing - This press Information is meant exclusively for trade press. - We do not approve publication in lay press. Ask pain patients what they expect from their treatment and the answer is simple: "I want to sleep through the whole night," or, "I want to be able to walk with my wife." They want relief with minimal side...
MISSISSAUGA, ON, July 25, 2012 /PRNewswire/ - Nuvo Research Inc. (TSX: NRI), a specialty pharmaceutical company dedicated to building a portfolio of products for the topical treatment of pain, today announced that the United States Patent Office has granted the reinstatement of Patent # 6,465,709 related to Synera(®) Patch (Synera Patent). The Synera Patent expiry date is July 7, 2020. Nuvo has listed the Synera Patent in the U.S. Food and Drug Administration's (FDA) Orange...
PHILADELPHIA, July 11, 2012 /PRNewswire/ -- Echo Therapeutics, Inc. (Nasdaq: ECTE), a company developing its needle-free Symphony® tCGM System as a non-invasive, wireless, transdermal continuous glucose monitoring system and its Prelude® SkinPrep System for transdermal drug delivery, today announced that it signed an amended license agreement with Ferndale Pharma Group, Inc. ("Ferndale") that grants Ferndale the right to develop, market and sell Prelude for painless,...
WASHINGTON, June 7, 2012 /PRNewswire-USNewswire/ -- Home remedies for jellyfish stings - such as vinegar, alcohol, meat tenderizer, baking soda and urine -may be less effective at relieving pain than plain hot water and lidocaine, according to a paper published online Tuesday in Annals of Emergency Medicine ("Evidence-Based Treatment of Jellyfish Stings in North America and Hawaii") http://www.annemergmed.com/webfiles/images/journals/ymem/ntward.pdf. (Logo:...
-- Pennsaid U.S. prescriptions increase 98% quarter-over-quarter -- New American College of Rheumatology Osteoarthritis Treatment Guidelines include recommendations for use of topical NSAIDS MISSISSAUGA, ON, April 12, 2012 /PRNewswire/ - Nuvo Research Inc. (TSX: NRI), a specialty pharmaceutical company dedicated to building a portfolio of products for the topical treatment of pain and the development of its immune modulating drug candidate WF10,...
